Pharmacogenomics is the branch of pharmaceutics which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with a drug's efficacy or toxicity.
By doing so, pharmacogenomics aims to develop rational means to optimise drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects.
Pharmacogenomics is the whole genome application of pharmacogenetics, which examines the single gene interactions with drugs.
Pharmacogenomics is the study of how an individual's genetic inheritance affects the body's response to drugs.
Pharmacogenomics holds the promise that drugs might one day be tailor-made for individuals and adapted to each person's own genetic makeup.
Pharmacogenomics has the potential to dramatically reduce the the estimated 100,000 deaths and 2 million hospitalizations that occur each year in the United States as the result of adverse drug response (1).
This web site offers searchable access to a number of Cambridge University Press dictionaries.
The genomics glossary, compiled by Mary Chitty contains terms about such areas as clinical genomics, drug discovery and development, functional genomics, proteomics, pharmacogenomics, sequencing, and structural genomics.
The site has a fully searchable database with over 2000 titles referenced.
